Rhenman & Partners Asset Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-895,000
| Closed | -$11.1M | – | 112 |
|
|
2016
Q4 | $11.1M | Buy |
895,000
+220,000
| +33% | +$2.74M | 2.13% | 13 |
|
|
2016
Q3 | $9.24M | Buy |
675,000
+50,000
| +8% | +$685K | 1.47% | 21 |
|
|
2016
Q2 | $4.62M | Buy |
625,000
+25,000
| +4% | +$185K | 0.82% | 47 |
|
|
2016
Q1 | $3.83M | Buy |
600,000
+170,000
| +40% | +$1.09M | 0.76% | 50 |
|
|
2015
Q4 | $2.69M | Hold |
430,000
| – | – | 0.41% | 72 |
|
|
2015
Q3 | $2.51M | Sell |
430,000
-20,000
| -4% | -$117K | 0.4% | 67 |
|
|
2015
Q2 | $3.72M | Buy |
450,000
+63,000
| +16% | +$521K | 0.45% | 73 |
|
|
2015
Q1 | $3.19M | Sell |
387,000
-10,000
| -3% | -$82.4K | 0.54% | 63 |
|
|
2014
Q4 | $2.73M | Sell |
397,000
-26,000
| -6% | -$179K | 0.79% | 51 |
|
|
2014
Q3 | $2.28M | Buy |
423,000
+33,000
| +8% | +$178K | 0.67% | 54 |
|
|
2014
Q2 | $2.48M | Buy |
390,000
+152,190
| +64% | +$969K | 0.74% | 52 |
|
|
2014
Q1 | $1.92M | Sell |
237,810
-462,190
| -66% | -$3.73M | 0.58% | 61 |
|
|
2013
Q4 | $4.77M | Buy |
+700,000
| New | +$4.77M | 1.87% | 14 |
|